These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 19035386)

  • 1. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiplatelet effects of omega-aminoalkoxylxanthones.
    Lin CN; Liou SS; Lai SC; Lin HC; Ko FN; Liu HW; Teng CM
    J Pharm Pharmacol; 1995 Jul; 47(7):588-94. PubMed ID: 8568627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet and vasorelaxing actions of some aporphinoids.
    Chen KS; Ko FN; Teng CM; Wu YC
    Planta Med; 1996 Apr; 62(2):133-6. PubMed ID: 8657745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids.
    Chen KS; Ko FN; Teng CM; Wu YC
    J Nat Prod; 1996 May; 59(5):531-4. PubMed ID: 8778245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, and cytotoxic and antiplatelet activities of oxime- and methyloxime-containing flavone, isoflavone, and xanthone derivatives.
    Wang TC; Chen IL; Lu CM; Kuo DH; Liao CH
    Chem Biodivers; 2005 Feb; 2(2):253-63. PubMed ID: 17191978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiaggregating and antithrombotic activities of new 1, 2, 3-triazolecarboxamides.
    Cwiklicki A; Rehse K
    Arch Pharm (Weinheim); 2004 Mar; 337(3):156-63. PubMed ID: 15038061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
    Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
    J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
    Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
    Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet and vasorelaxing actions of the acetoxy derivative of cedranediol isolated from Juniperus squamata.
    Teng CM; Lin CH; Kuo YH; Lin YL; Huang TF
    Planta Med; 1994 Jun; 60(3):209-13. PubMed ID: 8073084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
    Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
    Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antithrombotic effect of xanthone derivatives.
    Lin CN; Hsieh HK; Liou SJ; Ko HH; Lin HC; Chung MI; Ko FN; Liu HW; Teng CM
    J Pharm Pharmacol; 1996 Sep; 48(9):887-90. PubMed ID: 8910846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Nitrosoimino-3,6-dihydro-2H-1,3,4-thiadiazines with antiplatelet and antithrombotic properties.
    Rehse K; Brümmer U; Unsöld E
    Pharmazie; 1998 Dec; 53(12):820-4. PubMed ID: 9879566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzophenones and xanthones from Garcinia cantleyana var. cantleyana and their inhibitory activities on human low-density lipoprotein oxidation and platelet aggregation.
    Jantan I; Saputri FC
    Phytochemistry; 2012 Aug; 80():58-63. PubMed ID: 22640928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
    Yao FM; Sun CS
    Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
    Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
    Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.